While previous research has primarily focused on the role of CYFIP1 in neuronal development and neurodevelopmental disorders like autism, schizophrenia, and epilepsy(Abekhoukh and Bardoni 2014; Bonaccorso et al. 2015), recent evidence highlights its involvement in the carcinogenesis and progression of various cancers(Teng et al. 2016a, b; Chang et al. 2018; Limaye et al. 2022; Silva et al. 2009), suggesting context-specific modulation of CYFIP1 holds promise as a therapeutic approach for cancer treatment. Here, CYFIP1 is linked to schizophrenia.